SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: jay silberman who wrote (123)11/14/1997 12:43:00 AM
From: Gary105  Read Replies (1) | Respond to of 340
 
Page 36 of Decembers Individual Investor (just out) quotes 2 analysts:

Saks of Gruntal looks for $2.4 this yr and $3.75 next yr with target of $94 by end of next yr

Buermann of Merrill has target of $67 (presumably for '98) - bullish but doesnt see it attaining same p/e of US drug makers.

Article says Teva's R&D is subsidized (up to 50%) by Israeili govt (with payback if developed drugs are successful) and has strong collaboration with well known Weizmann Institute. Pipeline has drugs which target central nervous system and autoimmune disorders, including drugs for Alzheimers, Parkinsons and epilepsy.

I like the collaboration with Weizmann - analogous to a U.S. company doing collaborative work with M.I.T - access to great brainpower at low cost and with govt subsidy.

Gary



To: jay silberman who wrote (123)11/14/1997 1:07:00 AM
From: Uncle Mikey  Read Replies (2) | Respond to of 340
 
If I didn't already have a significant part of my "drug stock" allocation in Teva I would buy more. (Of course I can't anyway just yet, becuase I just sold some at a loss rather than pay taxes on some of my other things that made too much money.)

Make sense? It doesn't to me. But that's what I did.

Off topic - In addition to Telebras I also bought a little bit of Cifra recently (CFRAY). Cifra is sort of like a Mexican Wal-Mart, with whom they have an alliance They have 100 cities identified to open stores. Hey, Mexican retail is going to be a big trend over the next 20 years and I don't want to say I missed it.

International stocks (along with culture, language, student exchange) is an interest of mine. Among other things I coordinate an annual international confernce for teenagers. This year we had kids from 45 countries. But we have never had a kid from Israel. There just don't seem to be any (in the Northwest US that is.)

Anyway back on topic. Teva is undervalued, And I'm mad as hell, and not going to take it any more!

Mike